Doyle McManus is a Washington columnist for the Los Angeles Times. During his long career at The Times, he has been a foreign correspondent in the Middle East, a White House correspondent and a presidential campaign reporter, and was the paper’s Washington bureau chief from 1996 to 2008. He was director of the journalism program at Georgetown University from 2018 to 2022. McManus, a native of San Francisco, has lived in Washington, D.C., since 1983 but still considers Hermosa Beach his spiritual home.
Latest From This Author
Trump’s most controversial Cabinet nominees are ideologues and eccentrics chosen for loyalty. They are also foot soldiers in a power grab.
There’s plenty on Trump’s wish list to worry about. But here’s a look at which are worth losing sleep over and which may be harder for him to carry out.
The bottom line in the presidential election is clear: Kamala Harris would preserve, protect and defend the Constitution. Donald Trump would not.
Are you an undecided voter? Planning to hold your nose and vote for Trump? Please listen to his former advisors: He is a danger to democracy.
Trump will claim the election was rigged, and if he loses will challenge the results. Last time, the guardrails of democracy held. How about this time?
Trump hates windmills with the power of a thousand turbines. That could hurt California, which is becoming more reliant on renewable energy.
Harris would continue the internationalist policies of Biden and Obama. Trump would reprise his previous role as disrupter-in-chief.
JD Vance and Tim Walz met Tuesday for the vice presidential debate on CBS News. L.A. Times columnists provided live updates of the best and worst moments.
Column: Harris’ economic plan is a grab bag of targeted subsidies. Trump’s is nonsense on stilts
It’s still the economy. Whether Kamala Harris or Donald Trump will be president is up to a few million undecided voters in swing states. Guess what they care about.
Trump wants the right to fire civil servants he sees as disloyal: Cue IRS audits for Trump enemies, anti-vaxxers in the FDA, revenge prosecutions.